LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹28 Cr | ₹34 Cr | ₹36 Cr | ₹42 Cr | ₹38 Cr |
What is the latest Total Non-Current Liabilities ratio of LACTOSE (INDIA) ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹28 Cr |
Mar2023 | ₹34 Cr |
Mar2022 | ₹36 Cr |
Mar2021 | ₹42 Cr |
Mar2020 | ₹38 Cr |
How is Total Non-Current Liabilities of LACTOSE (INDIA) Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹28 Cr | -17.57 | |
Mar2023 | ₹34 Cr | -4.90 | |
Mar2022 | ₹36 Cr | -13.46 | |
Mar2021 | ₹42 Cr | 8.67 | |
Mar2020 | ₹38 Cr | - |
Compare Total Non-Current Liabilities of peers of LACTOSE (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LACTOSE (INDIA) | ₹216.0 Cr | -9.4% | -14.8% | 56.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -3.1% | -3.9% | 12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,931.0 Cr | -2.9% | -0.8% | 62.5% | Stock Analytics | |
CIPLA | ₹117,322.0 Cr | 1.1% | 0.3% | 1.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,116.0 Cr | -1.3% | -9.4% | -0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,752.0 Cr | -3.7% | -5.9% | 19.7% | Stock Analytics |
LACTOSE (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LACTOSE (INDIA) | -9.4% |
-14.8% |
56.8% |
SENSEX | -2.9% |
-0.1% |
6.8% |
You may also like the below Video Courses